These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

853 related items for PubMed ID: 8614416

  • 1. Antiestrogen inhibition of cell cycle progression in breast cancer cells in associated with inhibition of cyclin-dependent kinase activity and decreased retinoblastoma protein phosphorylation.
    Watts CK, Brady A, Sarcevic B, deFazio A, Musgrove EA, Sutherland RL.
    Mol Endocrinol; 1995 Dec; 9(12):1804-13. PubMed ID: 8614416
    [Abstract] [Full Text] [Related]

  • 2. Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2.
    Prall OW, Sarcevic B, Musgrove EA, Watts CK, Sutherland RL.
    J Biol Chem; 1997 Apr 18; 272(16):10882-94. PubMed ID: 9099745
    [Abstract] [Full Text] [Related]

  • 3. Estrogen regulates activity of cyclin-dependent kinases and retinoblastoma protein phosphorylation in breast cancer cells.
    Foster JS, Wimalasena J.
    Mol Endocrinol; 1996 May 18; 10(5):488-98. PubMed ID: 8732680
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Constitutive overexpression of cyclin D1 but not cyclin E confers acute resistance to antiestrogens in T-47D breast cancer cells.
    Hui R, Finney GL, Carroll JS, Lee CS, Musgrove EA, Sutherland RL.
    Cancer Res; 2002 Dec 01; 62(23):6916-23. PubMed ID: 12460907
    [Abstract] [Full Text] [Related]

  • 6. Multifaceted regulation of cell cycle progression by estrogen: regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function.
    Foster JS, Henley DC, Bukovsky A, Seth P, Wimalasena J.
    Mol Cell Biol; 2001 Feb 01; 21(3):794-810. PubMed ID: 11154267
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate.
    Liang YC, Lin-Shiau SY, Chen CF, Lin JK.
    J Cell Biochem; 1999 Oct 01; 75(1):1-12. PubMed ID: 10462699
    [Abstract] [Full Text] [Related]

  • 8. Mechanisms of growth arrest by c-myc antisense oligonucleotides in MCF-7 breast cancer cells: implications for the antiproliferative effects of antiestrogens.
    Carroll JS, Swarbrick A, Musgrove EA, Sutherland RL.
    Cancer Res; 2002 Jun 01; 62(11):3126-31. PubMed ID: 12036924
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
    Coppock DL, Buffolino P, Kopman C, Nathanson L.
    Exp Cell Res; 1995 Nov 01; 221(1):92-102. PubMed ID: 7589260
    [Abstract] [Full Text] [Related]

  • 10. Inhibitory effects of 1alpha,25-dihydroxyvitamin D(3) on the G(1)-S phase-controlling machinery.
    Jensen SS, Madsen MW, Lukas J, Binderup L, Bartek J.
    Mol Endocrinol; 2001 Aug 01; 15(8):1370-80. PubMed ID: 11463860
    [Abstract] [Full Text] [Related]

  • 11. CDK2 is a target for retinoic acid-mediated growth inhibition in MCF-7 human breast cancer cells.
    Teixeira C, Pratt MA.
    Mol Endocrinol; 1997 Aug 01; 11(9):1191-202. PubMed ID: 9259311
    [Abstract] [Full Text] [Related]

  • 12. Cyclin D2 activates Cdk2 in preference to Cdk4 in human breast epithelial cells.
    Sweeney KJ, Sarcevic B, Sutherland RL, Musgrove EA.
    Oncogene; 1997 Mar 20; 14(11):1329-40. PubMed ID: 9178893
    [Abstract] [Full Text] [Related]

  • 13. Downregulation of cyclin D1 alters cdk 4- and cdk 2-specific phosphorylation of retinoblastoma protein.
    Yu B, Lane ME, Pestell RG, Albanese C, Wadler S.
    Mol Cell Biol Res Commun; 2000 Jun 20; 3(6):352-9. PubMed ID: 11032757
    [Abstract] [Full Text] [Related]

  • 14. A pure estrogen antagonist inhibits cyclin E-Cdk2 activity in MCF-7 breast cancer cells and induces accumulation of p130-E2F4 complexes characteristic of quiescence.
    Carroll JS, Prall OW, Musgrove EA, Sutherland RL.
    J Biol Chem; 2000 Dec 08; 275(49):38221-9. PubMed ID: 10991938
    [Abstract] [Full Text] [Related]

  • 15. pRb and Cdk regulation by N-(4-hydroxyphenyl)retinamide.
    Panigone S, Debernardi S, Taya Y, Fontanella E, Airoldi R, Delia D.
    Oncogene; 2000 Aug 17; 19(35):4035-41. PubMed ID: 10962560
    [Abstract] [Full Text] [Related]

  • 16. Inducible expression of cyclin D1 in T-47D human breast cancer cells is sufficient for Cdk2 activation and pRB hyperphosphorylation.
    Musgrove EA, Sarcevic B, Sutherland RL.
    J Cell Biochem; 1996 Mar 01; 60(3):363-78. PubMed ID: 8867812
    [Abstract] [Full Text] [Related]

  • 17. G1 phase accumulation induced by UCN-01 is associated with dephosphorylation of Rb and CDK2 proteins as well as induction of CDK inhibitor p21/Cip1/WAF1/Sdi1 in p53-mutated human epidermoid carcinoma A431 cells.
    Akiyama T, Yoshida T, Tsujita T, Shimizu M, Mizukami T, Okabe M, Akinaga S.
    Cancer Res; 1997 Apr 15; 57(8):1495-501. PubMed ID: 9108451
    [Abstract] [Full Text] [Related]

  • 18. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells.
    Said TK, Medina D.
    Mol Carcinog; 1998 Jun 15; 22(2):128-43. PubMed ID: 9655257
    [Abstract] [Full Text] [Related]

  • 19. Antiprogestin inhibition of cell cycle progression in T-47D breast cancer cells is accompanied by induction of the cyclin-dependent kinase inhibitor p21.
    Musgrove EA, Lee CS, Cornish AL, Swarbrick A, Sutherland RL.
    Mol Endocrinol; 1997 Jan 15; 11(1):54-66. PubMed ID: 8994188
    [Abstract] [Full Text] [Related]

  • 20. Differential effects of retinoids and antiestrogens on cell cycle progression and cell cycle regulatory genes in human breast cancer cells.
    Wilcken NR, Sarcevic B, Musgrove EA, Sutherland RL.
    Cell Growth Differ; 1996 Jan 15; 7(1):65-74. PubMed ID: 8788034
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.